- $122.86bn
- $143.58bn
- $33.54bn
- 86
- 51
- 78
- 84
Annual balance sheet for Medtronic, fiscal year end - April 25th, USD millions except per share, conversion factor applied.
2021 April 30th | 2022 April 29th | 2023 April 28th | 2024 April 26th | 2025 April 25th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 10,817 | 10,573 | 7,959 | 8,005 | 8,965 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5,462 | 5,551 | 5,998 | 6,128 | 6,515 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 22,548 | 23,059 | 21,675 | 21,935 | 23,814 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6,219 | 6,267 | 6,610 | 7,143 | 7,937 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 93,083 | 90,981 | 90,948 | 89,981 | 91,680 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8,509 | 12,394 | 9,051 | 10,789 | 12,879 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 41,655 | 38,430 | 39,465 | 39,767 | 43,656 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 51,428 | 52,551 | 51,483 | 50,214 | 48,024 |
| Total Liabilities & Shareholders' Equity | 93,083 | 90,981 | 90,948 | 89,981 | 91,680 |
| Total Common Shares Outstanding |